Review
Published on 14 Jun 2024
Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407865
- 1,798 views
Type at least 3 characters
2,250 articles
Articles
Original Research
Published on 11 Jun 2024
Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer’s disease model mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1351792
- 1,786 views
Systematic Review
Published on 10 Jun 2024
Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377475
- 1,208 views
Editorial
Published on 10 Jun 2024
Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426157
- 506 views
Original Research
Published on 05 Jun 2024
Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364353
- 930 views
Original Research
Published on 04 Jun 2024
Carvedilol increases seizure resistance in a mouse model of SCN8A-derived epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397225
- 934 views
Original Research
Published on 04 Jun 2024
Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392729
- 1,081 views
Original Research
Published on 03 Jun 2024
Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387409
- 1,252 views
Mini Review
Published on 03 Jun 2024
A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387158
- 1,655 views
Mini Review
Published on 31 May 2024
Novel targets and therapies of metformin in dementia: old drug, new insights
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415740
- 1,210 views
- 1 citation
Original Research
Published on 30 May 2024
Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1342226
- 1,329 views
Review
Published on 30 May 2024
Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366061
- 1,849 views
Original Research
Published on 30 May 2024
Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308547
- 963 views
Original Research
Published on 27 May 2024
Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390187
- 1,038 views
- 5 citations
Review
Published on 27 May 2024
Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370411
- 2,063 views
- 1 citation
Review
Published on 24 May 2024
Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403232
- 3,147 views
- 1 citation